Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-010228
Filing Date
2022-08-15
Accepted
2022-08-15 17:04:12
Documents
1
Period of Report
2022-08-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-56896.html 4  
1 PRIMARY DOCUMENT marketforms-56896.xml 4 7086
  Complete submission text file 0001214659-22-010228.txt   8482
Mailing Address 15641 RED HILL AVENUE, SUITE 200 TUSTIN CA 92780
Business Address
AULT MILTON C III (Reporting) CIK: 0001212502 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 221166548

Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations